US Broker Ratings

Investor Outlook: Aurora Cannabis Inc. (ACB) Poised for 48.97% Upside in a Flourishing Sector

Aurora Cannabis Inc. (NASDAQ: ACB), a prominent player in the healthcare sector specifically within the drug manufacturing niche, continues to captivate investor interest despite the challenges faced by the cannabis..

Zhengye Biotechnology Holding L (ZYBT) Stock Analysis: Navigating a Niche in Veterinary Vaccines Amidst Market Challenges

Individual investors eyeing opportunities in the healthcare sector might find Zhengye Biotechnology Holding Limited (NASDAQ: ZYBT) a curious case. Operating in the drug manufacturing industry, Zhengye is a Chinese company..

UroGen Pharma Ltd. (URGN) Stock Analysis: Strong Buy Ratings and a 65% Potential Upside

In the ever-evolving biotechnology sector, UroGen Pharma Ltd. (NASDAQ: URGN) stands out as a promising contender with its innovative approach to urothelial and specialty cancers. With a market capitalization of..

Olema Pharmaceuticals, Inc. (OLMA) Stock Analysis: Exploring the 86.81% Potential Upside in Women’s Cancer Therapies

Investors seeking opportunities within the biopharmaceutical sector may want to turn their attention to Olema Pharmaceuticals, Inc. (NASDAQ: OLMA). The company, headquartered in San Francisco, California, is making significant strides..

Absci Corporation (ABSI) Stock Analysis: Exploring the 173.66% Potential Upside in Biotech AI Innovations

Absci Corporation (NASDAQ: ABSI) is capturing investor attention with its ambitious use of artificial intelligence (AI) in drug creation, a move that positions it uniquely within the biotechnology sector. As..

Erasca, Inc. (ERAS) Stock Analysis: An Investor’s Look at the 0.91% Potential Upside

Erasca, Inc. (NASDAQ: ERAS), a burgeoning player in the biotechnology sector, is catching investor attention with its focus on precision oncology therapies targeting RAS/MAPK pathway-driven cancers. With a current market..

Wave Life Sciences Ltd. (WVE) Growth Potential: Analysts Predict 141% Upside

Wave Life Sciences Ltd. (NASDAQ: WVE) is capturing the attention of investors with a robust growth outlook and significant upside potential. Operating in the biotechnology sector, this Singapore-based company is..

Evolent Health, Inc. (EVH) Stock Analysis: Navigating a 147% Potential Upside Amidst Healthcare Challenges

Evolent Health, Inc. (NYSE: EVH), a prominent player in the healthcare sector, operates within the health information services industry. Headquartered in Arlington, Virginia, Evolent focuses on providing specialty care management..

Pulse Biosciences, Inc (PLSE) Stock Analysis: Exploring a 53% Upside Potential

Pulse Biosciences, Inc (NASDAQ: PLSE) stands as an intriguing prospect for investors looking to capitalize on innovative breakthroughs in the healthcare sector. As a novel bioelectric medicine company, Pulse Biosciences..

Integra LifeSciences Holdings Corp (IART) Investor Outlook: Analyzing a 34% Potential Upside in the Medical Devices Sector

Investors looking to explore opportunities within the medical devices sector might find Integra LifeSciences Holdings Corp (IART) an intriguing proposition. As a player in the healthcare industry with a focus..

Opko Health, Inc. (OPK) Stock Analysis: Exploring a 173.72% Potential Upside in the Healthcare Sector

Investors with a keen interest in the healthcare sector may find Opko Health, Inc. (NASDAQ: OPK) an intriguing option, especially given its substantial potential upside of 173.72%. Despite recent challenges,..

Vera Therapeutics, Inc. (VERA) Stock Analysis: Unpacking a 59% Upside Potential

Vera Therapeutics, Inc. (NASDAQ: VERA) stands out in the biotechnology sector, drawing considerable attention from investors seeking growth in the healthcare industry. Despite its current challenges, the company’s innovative approach..

agilon health, inc. (AGL) Stock Analysis: Navigating a Challenging Healthcare Landscape with a 3.89% Potential Upside

agilon health, inc. (NYSE: AGL) operates within the healthcare sector, focusing on medical care facilities for seniors through its innovative platform. Based in Westerville, Ohio, the company offers a subscription-like..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: Evaluating a 13.30% Potential Upside

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH), a key player in the biotechnology sector, has been drawing attention with its focus on therapies for autoimmune diseases. With a market capitalization of $1.94..

Evotec SE (EVO) Stock Analysis: A Healthcare Innovator with a 55% Potential Upside

Evotec SE (EVO), a notable player on the healthcare scene, is drawing significant attention from investors, not least due to an intriguing potential upside of 55.27%. Headquartered in Hamburg, Germany,..

ANI Pharmaceuticals (ANIP) Stock Analysis: Exploring a 35.71% Potential Upside

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), a prominent player in the healthcare sector, has been capturing investor attention with its robust revenue growth and potential price upside. With a market capitalization..

MiMedx Group, Inc (MDXG) Stock Analysis: Significant Upside with 98.10% Potential Growth Awaits Investors

MiMedx Group, Inc. (NASDAQ: MDXG), a prominent player in the biotechnology sector specializing in healthcare solutions, stands out in the market with a compelling proposition for investors. With a market..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Exploring a 12.62% Upside Potential

Healthcare Services Group, Inc. (NASDAQ: HCSG) presents an intriguing opportunity for investors within the healthcare sector. With a market capitalization of $1.38 billion, this Pennsylvania-based company is a key player..

Teladoc Health, Inc. (TDOC) Stock Analysis: Navigating a 42% Potential Upside Amidst Financial Volatility

Teladoc Health, Inc. (NYSE: TDOC), a leader in the virtual healthcare space, presents a unique investment opportunity characterized by significant potential upside and a challenging financial landscape. As the company..

Harrow, Inc. (HROW) Stock Analysis: Unveiling a 61% Upside Potential in the Eye Care Pharma Sector

Harrow, Inc. (NASDAQ: HROW) is making waves in the healthcare sector, particularly within the specialized realm of ophthalmic pharmaceuticals. With a market capitalization of $1.62 billion, this Nashville-based company is..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds